Gsk (GLAXF) Current Taxes (2009 - 2026)

Gsk's Current Taxes history runs 18 years deep, the most recent figure standing at -$748.2 million for Q1 2026.

• In Q1 2026, Current Taxes rose 5.4% year-over-year to -$748.2 million; the TTM figure through Mar 2026 stood at -$748.2 million (up 5.4% YoY), while the FY2025 annual figure was -$656.6 million, down 173.07% from the prior year.
• Current Taxes was -$748.2 million for Q1 2026 at Gsk, down from -$662.4 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $902.3 million in Q4 2024 to a low of -$922.7 million in Q2 2024.
• Historically, Current Taxes has averaged -$371.7 million across 5 years, with a median of -$515.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Taxes soared 84.62% in 2022, then plunged 173.41% in 2025.
• A 5-year view of Current Taxes shows it stood at $552.4 million in 2022, then gained by 12.33% to $620.6 million in 2023, then soared by 45.4% to $902.3 million in 2024, then slumped by 173.41% to -$662.4 million in 2025, then fell by 12.95% to -$748.2 million in 2026.
• The last three Current Taxes figures came in at -$748.2 million (Q1 2026), -$662.4 million (Q4 2025), and -$437.2 million (Q3 2025), per Business Quant data.